Abstract |
Cardiometabolic syndrome has been linked with dietary modification. Therefore, we investigated the effects of D-ribose-L-cysteine (DRLC) in rats fed with high fructose high fat (HFHF) diet. Twenty rats (n = 5), divided into 4 groups were concurrently exposed to HFHF and/or DRLC (250 mg/kg, p.o) during the 8 weeks study. The result showed that compared to control group, HFHF group had significant impairment in lipid and glucose homeostasis, increased cardiac xanthine oxidase, systolic blood pressure, heart rate, % body weight change and fluid intake. Also, there were significant reductions in HDL-C, cardiac (GPX, NO&GGT), feed intake and relative heart weight in the latter, relative to the former. However, there were no significant differences in most of the observed physical and biochemical changes in HFHF + DRLC group compared to control. DRLC alone did not disrupt the level of biomarkers. Conclusively, DRLC prevented the manifestation of oxidative stress and cardiometabolic syndrome in HFHF-diet fed rats.
|
Authors | Abodunrin Adebayo Ojetola, Wale Johnson Adeyemi, Ubong Edem David, Temitayo Olabisi Ajibade, Olumuyiwa Abiola Adejumobi, Temidayo Olutayo Omobowale, Ademola Adetokunbo Oyagbemi, Adesoji Adedipe Fasanmade |
Journal | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
(Biomed Pharmacother)
Vol. 142
Pg. 112017
(Oct 2021)
ISSN: 1950-6007 [Electronic] France |
PMID | 34399203
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021. Published by Elsevier Masson SAS. |
Chemical References |
- Thiazolidines
- 2-(1',2',3',4'-tetrahydroxybutyl)thiazolidine-4-carboxylic acid
- Fructose
- Xanthine Oxidase
- Glucose
- Cysteine
|
Topics |
- Animals
- Blood Pressure
(physiology)
- Cysteine
(analogs & derivatives, pharmacology)
- Diet, High-Fat
(adverse effects)
- Fructose
- Glucose
(metabolism)
- Heart Rate
(physiology)
- Lipid Metabolism
(drug effects)
- Male
- Metabolic Syndrome
(etiology, prevention & control)
- Oxidative Stress
(drug effects)
- Rats
- Rats, Wistar
- Thiazolidines
(pharmacology)
- Xanthine Oxidase
(metabolism)
|